FDA approves Aurobindo’s generic Dilantin

DAYTON N.J. — Aurobindo Pharma announced Thursday that its generic equivalent of Dilantin (extended phenytoin sodium) capsules in 100-mg dosage strength had been approved by the Food and Drug Administration.

The anti-epileptic medication is meant for treating and preventing seizures in patients during or after neurosurgery.